Alamanda Polymers was formed in 2007 to satisfy a previously unmet need in the marketplace. Alamanda's scientists, having more than 10 years experience in the synthesis of polyamino acids, have developed a polymerization process that enables complete control over the molecular weight of its polyamino acids without the use of metal catalysts. Moreover, the process results in highly monodisperse products (polydispersity index: 1.01-1.2). Alamanda's process produces polypeptides and PEGylated polypeptides of exact chain lengths with batch-to-batch consistency. In other words, the product will contain ONLY polyamino acids of specified length, rather than a mixture.

Alamanda currently offers high-purity grade polyamino acids, batch sizes up to 5Kg, of the most commonly used homopolyamino acids. Furthermore, the catalogue contains PEGylated block co-polyamino acids that have never before been commercially available. Alamanda can also provide its expertise in polyamino acid chemistry or custom-synthesis services for contract research.

MANUFACTURING

Dr. Jeffrey Schreier, Ph.D.
Director

Alamanda's manufacturing team has 15 years experience in production ranging from commodity chemicals to niche pharmaceuticals.

BOARD OF DIRECTORS

Dr. Willy Vayaboury, Ph.D.
Chief Scientist, President

Joy Bowman
Chief Technical Officer,
Executive Vice President

A.A. Fulmer
Branch Manager, Propulsion R&D
Dynetics, Inc.

SCIENTIFIC BOARD

Dr. Alexander Kabanov, Ph.D.
Director of Center for Drug Delivery and Nanomedicine
University of Nebraska Medical Center

Dr. Gianfranco Pasut, Ph.D.
Polymer Conjugation and Drug Delivery Laboratory
Pharmaceutical Sciences Department
University of Padova

Dr. Michel Geffard, Ph.D., M.D.
Founder and President of IDRPHT
Director of Research at INSERM
University of Bordeaux II